Primary carnitine deficiency – diagnosis after heart transplantation: better late than never!
Open Access
- 10 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Orphanet Journal of Rare Diseases
- Vol. 15 (1), 1-6
- https://doi.org/10.1186/s13023-020-01371-2
Abstract
Primary carnitine deficiency due to mutations in the SLC22A5 gene is a rare but well-treatable metabolic disorder that puts patients at risk for metabolic decompensations, skeletal and cardiac myopathy and sudden cardiac death. We report on a 7-year-old boy diagnosed with primary carnitine deficiency 2 years after successful heart transplantation thanks his younger sister’s having been identified via expanded newborn screening during a pilot study evaluating an extension of the German newborn screening panel. As L-carnitine supplementation can prevent and mostly reverse clinical symptoms of primary carnitine deficiency, all patients with cardiomyopathy should be investigated for primary carnitine deficiency even if newborn screening results were unremarkable.Keywords
Other Versions
This publication has 21 references indexed in Scilit:
- Carnitine deficiency induces a short QT syndromeHeart Rhythm, 2016
- Neue Zielerkrankungen im NeugeborenenscreeningMonatsschrift Kinderheilkunde, 2015
- Primary carnitine deficiency cardiomyopathyInternational Journal of Cardiology, 2014
- Response to Chen et al.: Carnitine Uptake Defect (Primary Carnitine Deficiency): Risk in Genotype-Phenotype CorrelationHuman Mutation, 2013
- Primary Carnitine Deficiency Presents Atypically with Long QT Syndrome: A Case ReportJIMD Reports, 2011
- Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative projectGenetics in Medicine, 2011
- Disorders of carnitine transport and the carnitine cycleSeminars in Medical Genetics, Part C of the American Journal of Medical Genetics, 2006
- Novel OCTN2 mutations: No genotype–phenotype correlations: Early carnitine therapy prevents cardiomyopathyAmerican Journal of Medical Genetics, 2002
- Successful Carnitine Treatment in Two Siblings Having Lipid Storage Myopathy with Hypertrophic CardiomyopathyNeuropediatrics, 1985
- Tissue distribution of carnitine biosynthetic enzymes in manBiochimica et Biophysica Acta (BBA) - General Subjects, 1980